Journal: |
Kasr Al Ainy Med J 25:104–111
local
|
Volume: |
|
Abstract: |
Background
Epilepsy is a chronic neurological disorder, which has potentially adverse cognitive
and psychosocial consequences.
Objectives
To assess the quality of life (QOL) of adolescents with epilepsy (AWE) and their
families and also factors affecting it, related to both the disease burden and the
antiepileptic drug.
Patients and methods
A cross-sectional study was done on 217 AWE and one parent each.
Sociodemographic and disease-related data were collected. Patients completed
the QOL in epilepsy questionnaire (AD-48) and pediatric epilepsy side effects
questionnaire. The parents completed impact of epilepsy on QOL questionnaire.
Results
Mean patients’ age was 14.33 years old, having disease since a mean duration of
6.62 years. Overall, 59.5% of them received polytherapy, with 37.3% having
received new line of drugs. Approximately one-third of them had partial
seizures. Half of them had one or two attacks per month. The mean total QOL
score was 55.91±5.55. The largest percentage of parents reported that epilepsy
had worse effects on their attitude, family change, general well-being, and
adolescents’ QOL. There are significant relationships between QOL and mother
education, age group, disease duration, seizures frequency, and type and line of
antiepileptic drugs. There are significant negative correlations between all pediatric
epilepsy side effects questionnaire domains and QOL.
Conclusions
Epilepsy had adverse effect on AWE and their families. Illiterate mothers, older,
increasing duration, seizure frequency, generalized type, and being on old or
combined drug regimens are the predictors of poor QOL.
Keywords:
adolescents, epilepsy, predictor, quality of life
|
|
|